Annual Interest Expense
$50.00 K
-$3000.00-5.66%
31 December 2023
Summary:
Windtree Therapeutics annual interest expense is currently $50.00 thousand, with the most recent change of -$3000.00 (-5.66%) on 31 December 2023. During the last 3 years, it has fallen by -$75.00 thousand (-60.00%). WINT annual interest expense is now -98.91% below its all-time high of $4.60 million, reached on 31 December 2014.WINT Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$110.00 K
+$97.00 K+746.15%
30 June 2024
Summary:
Windtree Therapeutics quarterly interest expense is currently $110.00 thousand, with the most recent change of +$97.00 thousand (+746.15%) on 30 June 2024. Over the past year, it has increased by +$97.00 thousand (+746.15%). WINT quarterly interest expense is now -92.64% below its all-time high of $1.50 million, reached on 30 September 2015.WINT Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$148.00 K
+$97.00 K+190.20%
30 June 2024
Summary:
Windtree Therapeutics TTM interest expense is currently $148.00 thousand, with the most recent change of +$97.00 thousand (+190.20%) on 30 June 2024. Over the past year, it has increased by +$97.00 thousand (+190.20%). WINT TTM interest expense is now -97.13% below its all-time high of $5.16 million, reached on 30 September 2015.WINT TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WINT Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -5.7% | +746.1% | +190.2% |
3 y3 years | -60.0% | +685.7% | +41.0% |
5 y5 years | -96.5% | +4.8% | -86.8% |
WINT Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -60.0% | at low | at high | +816.7% | at high | +196.0% |
5 y | 5 years | -96.5% | at low | -19.7% | +2650.0% | -86.8% | +196.0% |
alltime | all time | -98.9% | +92.3% | -92.6% | +833.3% | -97.1% | +825.0% |
Windtree Therapeutics Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | - | $110.00 K(+746.2%) | $148.00 K(+190.2%) |
Mar 2024 | - | $13.00 K(+8.3%) | $51.00 K(+2.0%) |
Dec 2023 | $50.00 K(-5.7%) | $12.00 K(-7.7%) | $50.00 K(-2.0%) |
Sept 2023 | - | $13.00 K(0.0%) | $51.00 K(-1.9%) |
June 2023 | - | $13.00 K(+8.3%) | $52.00 K(0.0%) |
Mar 2023 | - | $12.00 K(-7.7%) | $52.00 K(-1.9%) |
Dec 2022 | $53.00 K(-53.5%) | $13.00 K(-7.1%) | $53.00 K(0.0%) |
Sept 2022 | - | $14.00 K(+7.7%) | $53.00 K(0.0%) |
June 2022 | - | $13.00 K(0.0%) | $53.00 K(-38.4%) |
Mar 2022 | - | $13.00 K(0.0%) | $86.00 K(-24.6%) |
Dec 2021 | $114.00 K(-8.8%) | $13.00 K(-7.1%) | $114.00 K(+8.6%) |
Sept 2021 | - | $14.00 K(-69.6%) | $105.00 K(-23.4%) |
June 2021 | - | $46.00 K(+12.2%) | $137.00 K(+12.3%) |
Mar 2021 | - | $41.00 K(+925.0%) | $122.00 K(-2.4%) |
Dec 2020 | $125.00 K(-74.7%) | $4000.00(-91.3%) | $125.00 K(-51.6%) |
Sept 2020 | - | $46.00 K(+48.4%) | $258.00 K(-18.6%) |
June 2020 | - | $31.00 K(-29.5%) | $317.00 K(-21.3%) |
Mar 2020 | - | $44.00 K(-67.9%) | $403.00 K(-18.6%) |
Dec 2019 | $495.00 K(-64.9%) | $137.00 K(+30.5%) | $495.00 K(-56.0%) |
Sept 2019 | - | $105.00 K(-10.3%) | $1.13 M(-24.0%) |
June 2019 | - | $117.00 K(-14.0%) | $1.48 M(+1.7%) |
Mar 2019 | - | $136.00 K(-82.3%) | $1.46 M(+3.3%) |
Dec 2018 | $1.41 M(-24.4%) | $767.00 K(+66.7%) | $1.41 M(+124.7%) |
Sept 2018 | - | $460.00 K(+400.0%) | $627.00 K(-23.4%) |
June 2018 | - | $92.00 K(+2.2%) | $819.00 K(-39.0%) |
Mar 2018 | - | $90.00 K(-700.0%) | $1.34 M(-28.0%) |
Dec 2017 | $1.86 M(-26.0%) | -$15.00 K(-102.3%) | $1.86 M(-25.2%) |
Sept 2017 | - | $652.00 K(+6.0%) | $2.49 M(+0.2%) |
June 2017 | - | $615.00 K(+0.7%) | $2.48 M(-0.9%) |
Mar 2017 | - | $611.00 K(0.0%) | $2.51 M(-0.4%) |
Dec 2016 | $2.52 M | $611.00 K(-5.7%) | $2.52 M(-0.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2016 | - | $648.00 K(+1.7%) | $2.53 M(-25.1%) |
June 2016 | - | $637.00 K(+2.4%) | $3.38 M(-15.6%) |
Mar 2016 | - | $622.00 K(+0.2%) | $4.00 M(-12.8%) |
Dec 2015 | $4.58 M(-0.3%) | $621.00 K(-58.5%) | $4.58 M(-11.2%) |
Sept 2015 | - | $1.50 M(+18.7%) | $5.16 M(+6.7%) |
June 2015 | - | $1.26 M(+4.3%) | $4.84 M(+2.7%) |
Mar 2015 | - | $1.21 M(+0.6%) | $4.71 M(+2.5%) |
Dec 2014 | $4.60 M(+212.5%) | $1.20 M(+2.5%) | $4.60 M(+15.1%) |
Sept 2014 | - | $1.17 M(+3.6%) | $3.99 M(+25.8%) |
June 2014 | - | $1.13 M(+3.5%) | $3.17 M(+33.0%) |
Mar 2014 | - | $1.09 M(+82.8%) | $2.39 M(+62.2%) |
Dec 2013 | $1.47 M(+2480.7%) | $598.00 K(+69.4%) | $1.47 M(+60.2%) |
Sept 2013 | - | $353.00 K(+2.9%) | $919.00 K(+61.2%) |
June 2013 | - | $343.00 K(+92.7%) | $570.00 K(+146.8%) |
Mar 2013 | - | $178.00 K(+295.6%) | $231.00 K(+305.3%) |
Dec 2012 | $57.00 K(+119.2%) | $45.00 K(+1025.0%) | $57.00 K(+256.3%) |
Sept 2012 | - | $4000.00(0.0%) | $16.00 K(-11.1%) |
June 2012 | - | $4000.00(0.0%) | $18.00 K(-10.0%) |
Mar 2012 | - | $4000.00(0.0%) | $20.00 K(-23.1%) |
Dec 2011 | $26.00 K(-92.7%) | $4000.00(-33.3%) | $26.00 K(-10.3%) |
Sept 2011 | - | $6000.00(0.0%) | $29.00 K(-31.0%) |
June 2011 | - | $6000.00(-40.0%) | $42.00 K(-66.4%) |
Mar 2011 | - | $10.00 K(+42.9%) | $125.00 K(-65.0%) |
Dec 2010 | $357.00 K(-67.0%) | $7000.00(-63.2%) | $357.00 K(-40.3%) |
Sept 2010 | - | $19.00 K(-78.7%) | $598.00 K(-28.0%) |
June 2010 | - | $89.00 K(-63.2%) | $831.00 K(-18.7%) |
Mar 2010 | - | $242.00 K(-2.4%) | $1.02 M(-5.5%) |
Dec 2009 | $1.08 M(-33.0%) | $248.00 K(-1.6%) | $1.08 M(+29.7%) |
Sept 2009 | - | $252.00 K(-10.0%) | $834.00 K(+43.3%) |
June 2009 | - | $280.00 K(-7.3%) | $582.00 K(+92.7%) |
Mar 2009 | - | $302.00 K | $302.00 K |
Dec 2008 | $1.61 M | - | - |
FAQ
- What is Windtree Therapeutics annual interest expense?
- What is the all time high annual interest expense for Windtree Therapeutics?
- What is Windtree Therapeutics annual interest expense year-on-year change?
- What is Windtree Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Windtree Therapeutics?
- What is Windtree Therapeutics quarterly interest expense year-on-year change?
- What is Windtree Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Windtree Therapeutics?
- What is Windtree Therapeutics TTM interest expense year-on-year change?
What is Windtree Therapeutics annual interest expense?
The current annual interest expense of WINT is $50.00 K
What is the all time high annual interest expense for Windtree Therapeutics?
Windtree Therapeutics all-time high annual interest expense is $4.60 M
What is Windtree Therapeutics annual interest expense year-on-year change?
Over the past year, WINT annual interest expense has changed by -$3000.00 (-5.66%)
What is Windtree Therapeutics quarterly interest expense?
The current quarterly interest expense of WINT is $110.00 K
What is the all time high quarterly interest expense for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly interest expense is $1.50 M
What is Windtree Therapeutics quarterly interest expense year-on-year change?
Over the past year, WINT quarterly interest expense has changed by +$97.00 K (+746.15%)
What is Windtree Therapeutics TTM interest expense?
The current TTM interest expense of WINT is $148.00 K
What is the all time high TTM interest expense for Windtree Therapeutics?
Windtree Therapeutics all-time high TTM interest expense is $5.16 M
What is Windtree Therapeutics TTM interest expense year-on-year change?
Over the past year, WINT TTM interest expense has changed by +$97.00 K (+190.20%)